glutamic acid and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

glutamic acid has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bender, B; Closhen, D; Gerigk, M; Kuhlmann, CR; Lessmann, V; Luhmann, HJ1

Other Studies

1 other study(ies) available for glutamic acid and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Fluvastatin prevents glutamate-induced blood-brain-barrier disruption in vitro.
    Life sciences, 2008, Jun-20, Volume: 82, Issue:25-26

    Topics: Animals; Blood-Brain Barrier; Calcium; Cell Line; Dose-Response Relationship, Drug; Electric Impedance; Endothelial Cells; Fatty Acids, Monounsaturated; Fluvastatin; Glutamic Acid; Indoles; Intracellular Space; Myosin Light Chains; Nitric Oxide; Oxidative Stress; Phosphorylation; Rats; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Time Factors

2008